Narrow Results

Alliance between AGT Biosciences and Starpharma.

First Australian Biotech Company to List on HKSE.

Breakthrough in Transdermal Drug Discovery Technology.

Acrux Licenses MDTS Technology to Eli Lilly got Animal Health Products.

Biota Secures SARS Testing Agreement with US Government Research Agencies.

SysArris in Bio Partnering Europe 2003.

Shantha Bio to Launch Streptokinase by Year-end.

Lupin Receives US FDA Approval to Launch Ceftriaxone.

MerLion Pharma Collaborates with Schering-Plough in Drug Discovery Research.

Quest Pharmaceutical Sets up Taiwanese Subsidiary.

BenQ to Invest in Nanjing's Medical Facilities.

AUSTRALIA – Well-known antibiotic amoxycillin found to be ineffective cough treatment.

AUSTRALIA – Bring the noise: has technology made us scared of silence?

INDIA – Biocon receives marketing authorization for novel biologic itolizumab for psoriasis.

ISRAEL – Aspireo reports Somatoprim Phase Ib interim data.

JAPAN – Daiichi Sankyo and Amplimmune announce strategic alliance to develop AMP-110 therapy for autoimmune disease.

JAPAN – Eisai signs agreement with Epizyme and Roche Molecular Systems to develop companion diagnostic.

THE PHILIPPINES – Asia-Pacific Analysis: The growth of stem-cell therapy.

THE PHILIPPINES – Is the world ready for scientific diplomacy?

UNITED KINGDOM – ARIAD and the U.K. National Cancer Research Institute to collaborate on SPIRIT 3 clinical study.

UNITED KINGDOM – Vision research collaboration on novel treatment for wet age-related macular degeneration.

UNITED STATES – Reducing medical mistakes: Two recently published studies support the use of DNA testing on biopsy samples to prevent misdiagnoses.

UNITED STATES – CoDa Therapeutics reports positive results from Phase IIb Study of NEXAGON® in chronic venous leg ulcers.

UNITED STATES – Inovio Pharmaceuticals to initiate clinical trial for its hepatitis C therapeutic vaccine later this year.

UNITED STATES – Jolt to brain eases pain without drugs.

UNITED STATES – Can a new vaccine prevent colon cancer?

UNITED STATES – Immunovaccine's DPX-Survivac produces sustained, dose related immune responses in Phase I ovarian cancer study.

Singapore and Korea research institutes to collaborate on biomass-to-chemicals research.

Nobel prize in medicine goes to cell transport discovery.

Tri-institutional Therapeutics Discovery Institute, Inc. launched.

Agilent Technologies collaborates with Florey Institute of Neuroscience and Mental Health.

Quintiles selected by Muscular Dystrophy Association to develop U.S. Disease Registry.

Joslin Diabetes Center forms alliance with John & Johnson Innovation to identify exercise-related drug targets to improve diabetes management.

CLINATEC chairman Alim-Louis Benabid honored for Parkinson's disease work.

AstraZeneca enters co-promotion agreement with Janssen in Japan for innovative prostrate cancer treatment.

Scotland demonstrates its collaborative approach to cell therapy development.

KineMed forms agreement with Amgen to develop kinetic biomarkers of brain proteinopathies.

IMCD group opens its first pharmaceutical laboratory.

Napier Healthcare wins Promising Healthcare IT Company of the Year 2013 Award from Frost & Sullivan Singapore.

AB SCIEX opens R&D center in Singapore; hopes to drive scientific innovation.

Sanford-Burnham and Daiichi Sankyo form alliance to study novel drug targets in cardiovascular metabolic diseases.

Sigma-Aldrich® to launch Austrianova's Cell-in-a-Box® Kit for research use.

ASLAN Pharmaceuticals signs agreement with CSL to develop novel therapy for asthma.

Self-assembling peptides for bone regeneration and drug delivery.

Verisante Technology, Inc. receives the 2014 North American Technology Innovation Leadership of the Year Award from Frost & Sullivan.

Agilent Technologies partners Women in Science, Engineering and Technology in Korea.

Mundipharma and Genewel sign agreement across key global markets for licensing and promotion of Medifoam®.

Janssen collaborates with ViiV Healthcare to develop two-drug single tablet regimen for the maintenance treatment of people living with HIV.

AbbVie opens expanded manufacturing facility in Sligo, Ireland.

AMRI to Acquire Oso Biopharmaceuticals Manufacturing.

Merck to collaborate with Sysmex Inostics on a blood-based RAS biomarker test.

Igenbio establishes direct presence in Japan.

Mesoblast accelerates plans for commercial manufacturing operations in Singapore.

Celerion and Korean Drug Development Fund form collaboration to strengthen early phase clinical research in South Korea.

Dr. Carolyn Mountford, University of Newcastle, Australia receives Agilent Technologies Thought Leader Award.

PHARM Connect – The business summit covering a full industry.

New topics for the Next Generation Sequencing & Single Cell Genomics Asia Congress confirmed.

Registration opened for Oxford Global's 6th Annual Next Generation Sequencing Congress.

Registration opened for Oxford Global's 4th Annual Next Generation Sequencing Asia Congress.

Neusoft Partners with Hony Capital and Goldman Sachs to create the new champion in the global healthcare community.

The Medicines Company and SciClone Pharmaceuticals establish strategic partnership for two cardiovascular products in China.

Syngenta receives Chinese import approval for Agrisure Viptera® corn trait.

TWi Biotechnology receives Notice of Patent Allowance in China for its lead drug candidate for the indication of type II diabetes.

China's largest fertilizer producer Sinofert and IBM use mobile to help farms increase crop yields.

Cardiome enters development and commercialization agreement with Eddingpharm.

Milestone Scientific signs distribution agreement for intra-articular instrument in China.

HUYA Bioscience International establishes alliance with China Wuqing Development Area.

Elekta Flexitron brachytherapy treatment delivery available in China.

Hong Kong pharmaceutical company pioneers world's first ever high-performance anti-pruritus nanopatch.

Singapore-Based Asian American Medical Group and Rich Tree Holdings Break Ground on Zhuhai-Singapore Life Science Park; Advanced Diagnostic and Wellness Medical Centre Will Bring World-Class Services to Southern China in 2018.

ASLAN Pharmaceuticals Opens China Office.

China to Improve Basic Science Research.

Chinese Scientists Edit Genes to Resist HIV in Embryos.

Scientists Find How Red Wine Compound Protects Heart.

Alliance for Stem Cell Technologies Established in Guangzhou.

China and Germany Keen to Deepen R&D Cooperation.

Study Unveils Novel Crosstalk Mechanism between Mitochondrial Translation and Cytoplasmic Translation.

China's Seed Haven Protects Endangered Plants.

Scientists Find that miR-155 Suppresses ErbB2-induced Malignant Transformation.

Nectar and Scent Secretion Patterns Reflect Floral Color Change Rhythm in Quisqualis indica.

Let $\mathrm{\Gamma }=(V,E)$ be a finite undirected graph without loops or multiple edges. A non-empty set of vertices $S\subseteq V$ is called defensive alliance if every vertex in $S$ have at least one more neighbors inside of $S$ than it has outside of $S$. A non-empty set of vertices $S\subseteq V$ is called a dominating set if every vertex not in $S$ is adjacent to at least one member of $S$. A defensive alliance dominating set is called global. The global defensive alliance number ${\gamma }_a(\mathrm{\Gamma })$ is defined as the minimum cardinality among all global defensive alliances. In this paper, we initiate the study of the global defensive alliance number of zero-divisor graphs $\mathrm{\Gamma }(R)$ with $R$ is a finite commutative ring. Hence, we calculate ${\gamma }_a(\mathrm{\Gamma }(R))$ for some usual kind of rings. We finish by a complete characterization of rings with ${\gamma }_a(\mathrm{\Gamma }(R))=1,\mathrm{\text{or}}2$.

The evolution of the fuel injection technology for diesel engines initiated and repeatedly innovated since 1922 by Robert Bosch GmbH of Stuttgart, Germany, is used to illustrate the management and policy adaptations necessary to carry out repeated innovations as technologies move through different innovation patterns — transformation (first-of-a-kind), transition (major redesign) and normal (incremental) — and as they evolve from simple to complex. Special attention is given to the role of cooperative alliances in the innovation, knowledge management and decision-making associated with the development of the diesel injection technology. As the technology has become ever more complex, the Bosch innovation activities have manifested a process of co-evolution between a continuously adapting network of supplier and user organisations and diesel injection technology that has occurred as part of an ever-changing environment (e.g., market, public policy).

Water security has become one of the most important topics in China’s relations with neighboring countries. Currently, there is an asymmetric interdependence and a structure of “low conflict and low cooperation” between China and neighboring countries, which leads to a sense of insecurity over the water resource utilization. Consequently, some of these countries are trying to form a potentially strategic alliance with other countries outside the region to contain China’s “water power,” which will exert negative impact on China’s relationship with these neighboring countries and change the overall security environment on China’s peripheries. In the future, however, China’s strategic advantage on water resources could serve as the basis of diplomatic breakthroughs to promote regional water governance in alignment with China’s national interest. China should take advantage of its strategic position as the “Water Tower in Asia” to formulate a water resource security strategy, establish feasible sharing and compensation mechanisms, and create new arenas for its neighboring diplomacy.

The Albanian–Chinese alliance existed between 1960 and 1978, an unusual relationship due to the roles and influences of both in and out of the Communist Bloc. Although ideological affinity is generally regarded as essential to the performance of an alliance, contingency and circumstance also matter. The main factors that influenced the character of the Sino-Albanian alliance will be revealed through the official correspondence of that time between the two countries, founded mainly in Central State Archive. Albania and China collaborated for 18 years and after their ideological conflicts Albania followed a self-isolation policy. After the fall of Communism in Albania, bilateral ties developed under the new circumstances for several years. It was China’s Belt and Road Initiative (BRI) that helped create new conditions for cooperation. Through a descriptive analysis, this paper presumes/hypothesizes whether being old allies in the past can be considered as a prerequisite for cooperation in the present. In the beginning, Albania assessed the potential of BRI and proposed some important projects with China, but lately it has shown more ambivalence and reluctance toward the “$16+1$” mechanism. We also examine the main factors on the Albanian side that may bolster or undercut future bilateral cooperation under the “16+1” framework.

America’s Indo-Pacific strategy is essentially a combination of its Asia-Pacific and Indian strategies: through the consolidation of its strategic alliances, it can deepen its relations with Asia-Pacific allies, and through its “wedging strategy” it can pull India into its orbit to become a strategic “fulcrum” bridging the region. India was both a key member and leader of the non-aligned movement, while also previously forming a “quasi-alliance” with the Soviet Union. At present, it has responded to the US Indo-Pacific strategy with cautious initiative. From the vantage point of a state targeted vis-à-vis a wedging strategy, India’s strategic behavior is shaped by the strategic environment, its primary strategic objectives, and the relations between allies within the context of a unique strategic environment. This paper identifies two types of strategic environments: the general strategic environment and the specialized strategic environment; it further identifies primary strategic objectives as economic development, sovereign integrity and independence, national security and great state status (especially with respect to that of regional or global major powers); meanwhile, the alliance relationship is defined according to the extent to which there are divisions across state interests and the capacity of states to act autonomously vis-à-vis the alliance. Through an analysis of India’s diplomatic experiences, this paper argues that against the backdrop of America’s “Indo-Pacific” strategy and a lose general strategic environment, the primary strategic objective of achieving major state status and a “large divide over interests and a major space for autonomous action” shape India’s cautious initiative with respect to its alliance relationships.

2021 was a watershed year for the US, Japan, India, and Australia vis-à-vis their Quadrilateral Cooperation mechanism, which successfully transitioned from a loose coordinating body to a grouping of allied actors. Reviewing the historical development of the Quad, three distinct phases can be identified: the conceptual stage, the strategy development stage, and the third phase of evolution toward an alliance. During the first two phases, the Quad was not more than a loose coordinating structure, but in the last phase, it started to take on the characteristics of an alliance-like body. The primary reason we can conclude that it has evolved into an alliance body is that the organization has started to mold behavioral norms, and it further aims to establish a monopoly over the provision of norms in the Indo-Pacific region. Three factors have played a role in driving the US, Japan, India, and Australia to build the Quad into an alliance body: first is the pursuit of general interests; second is the global situation brought about by the COVID-19 pandemic and its impact on their relations; third is the formation of a shared objective. These three factors combined worked to shape the Quad into an alliance. As the Quad primarily targets China, its emergence as an alliance will have impacts on China’s security environment that cannot be ignored. In response, China should implement its “neighborhood first” strategy, promote the $1+1$ Leader’s Summit on Mutual Respect with its neighboring countries, and advance the comprehensive deepening of economic cooperation between China and ASEAN. These steps can help China respond to the rapidly changing Indo-Pacific geo-political situation.

This study aims to contribute to drawing a more complete picture of the role of multilateral economic and political institutions. Particularly, we pursue answers to questions such as how much influence participation in multilateral trade arrangements and military alliance has on bilateral trade of the states involved. Our results show that political institutions, set apart from trade issues, do affect bilateral trade--even though these effects are demonstrably smaller than those that occur within economic institutions. Military disputes between two states are sure to decrease bilateral trade, while joint democracy and policy similarity between two states, although moderate, increase bilateral trade, but military alliance is indeterminate.

Alliance diplomacy once occupied a significant position in China's foreign policy, but academic community fails to explore the historical phenomena in a systematic and in-depth way. This chapter will take the Sino-Albanian alliance as a case in an effort to examine the role of ideology in the rise and fall of the alliance. In an era where ideology prevailed, a shared ideology played a decisive role in the formation of the Sino-Albanian alliance, but China's security and economic assistance to Albania played a larger role in the maintenance of the alliance. As China and Albania clashed over a variety of issues, the conflicting aspect of their ideologies came to be a bone of contention and helped to cause the collapse of the alliance, whose members were extremely asymmetrical, geographically separated by thousands of miles and had no historical connection.